How Moderna Went From Coronavirus Sequence to a Phase-1-Ready Vaccine Candidate in 42 DaysThe Motley Fool • 08/06/20
Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
AWS Powers Moderna’s Digital Biotechnology Platform to Develop New Class of Vaccines and TherapeuticsBusiness Wire • 08/05/20
Moderna Posts Q2 Beat, Reportedly Closes In On Coronavirus Vaccine Deal With Swiss GovernmentBenzinga • 08/05/20
Moderna Plans To Charge $32-37 Per Covid Vaccine Dose, Discussing Supply Deals With Several CountriesForbes • 08/05/20
Moderna's stock rallies as it moves forward with enrolling its Phase 3 COVID-19 vaccine trialMarket Watch • 08/05/20
Moderna Reports Second Quarter 2020 Financial Results and Provides Business UpdatesBusiness Wire • 08/05/20
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?The Motley Fool • 08/04/20